{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:20:07Z","timestamp":1784280007834,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T00:00:00Z","timestamp":1323820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s12185-011-0976-7","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T03:04:40Z","timestamp":1323745480000},"page":"86-94","source":"Crossref","is-referenced-by-count":20,"title":["Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation"],"prefix":"10.1007","volume":"95","author":[{"given":"Alain M.","family":"Ngoma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyoshi","family":"Noji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syunnichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Nollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ohto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"976_CR1","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1182\/blood.V100.12.3877","volume":"100","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Brand R, Apperley J, Biezen Av A, Bandini G, Devergie A, et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood. 2002;100:3877\u201386.","journal-title":"Blood"},{"key":"976_CR2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.54.101601.152339","volume":"54","author":"GB Vogelsang","year":"2003","unstructured":"Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med. 2003;54:29\u201352.","journal-title":"Annu Rev Med"},{"key":"976_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/15258160050079407","volume":"9","author":"JL Ferrara","year":"2000","unstructured":"Ferrara JL. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Res. 2000;9:299\u2013306.","journal-title":"J Hematother Stem Res"},{"key":"976_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.immunol.25.022106.141606","volume":"25","author":"LA Welniak","year":"2007","unstructured":"Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25:139\u201370.","journal-title":"Annu Rev Immunol"},{"key":"976_CR5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151\u201364.","journal-title":"J Immunol"},{"key":"976_CR6","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.172.6.1701","volume":"172","author":"F Powrie","year":"1990","unstructured":"Powrie F, Mason D. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J Exp Med. 1990;172:1701\u20138.","journal-title":"J Exp Med"},{"key":"976_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1084\/jem.161.1.72","volume":"161","author":"S Sakaguchi","year":"1985","unstructured":"Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced by elimination of T cell subset: Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med. 1985;161:72\u201387.","journal-title":"J Exp Med"},{"key":"976_CR8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science. 2003;299:1057\u201361.","journal-title":"Science"},{"key":"976_CR9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. FOXP3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330\u20136.","journal-title":"Nat Immunol"},{"key":"976_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:337\u201342.","journal-title":"Nat Immunol"},{"key":"976_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","volume":"164","author":"AM Thorton","year":"2000","unstructured":"Thorton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164:183\u201390.","journal-title":"J Immunol"},{"key":"976_CR12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","volume":"101","author":"S Sakaguchi","year":"2000","unstructured":"Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell. 2000;101:455\u20138.","journal-title":"Cell"},{"key":"976_CR13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","volume":"420","author":"Y Belkaid","year":"2002","unstructured":"Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502\u20137.","journal-title":"Nature"},{"key":"976_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.coi.2004.01.010","volume":"16","author":"M Terabe","year":"2004","unstructured":"Terabe M, Berzofsky JA. Immunoregulatory T cells in tumor immunity. Curr Opin Immunol. 2004;16:157\u201362.","journal-title":"Curr Opin Immunol"},{"key":"976_CR15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20020090","volume":"196","author":"JL Cohen","year":"2002","unstructured":"Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4+CD25+ immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196:401\u20136.","journal-title":"J Exp Med"},{"key":"976_CR16","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","volume":"99","author":"PA Taylor","year":"2002","unstructured":"Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99:3493\u20139.","journal-title":"Blood"},{"key":"976_CR17","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","volume":"105","author":"J Ermann","year":"2005","unstructured":"Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP, et al. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood. 2005;105:2220\u20136.","journal-title":"Blood"},{"key":"976_CR18","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2004-05-1850","volume":"104","author":"PA Taylor","year":"2004","unstructured":"Taylor PA, Panoskaltsis-Mortari A, Swedin JM, Lucas PJ, Gress RE, Levine BL, et al. l-Selectin(hi) but not the l-selectin(lo) CD4+CD25+ regulatory T cells are potent inhibitors of GVHD and BM graft rejection. Blood. 2004;104:3804\u201312.","journal-title":"Blood"},{"key":"976_CR19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20041709","volume":"201","author":"I Lee","year":"2005","unstructured":"Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. Recruitment of Foxp3+\u00a0T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med. 2005;201:1037\u201344.","journal-title":"J Exp Med"},{"key":"976_CR20","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood-2005-04-1632","volume":"106","author":"CA Wysocki","year":"2005","unstructured":"Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, Taylor PA, McKinnon KP, Su L, et al. Critical role of CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood. 2005;106:3300\u20137.","journal-title":"Blood"},{"key":"976_CR21","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2003-06-2073","volume":"103","author":"FJ Clark","year":"2004","unstructured":"Clark FJ, Gregg R, Piper K, Dunnion D, Freeman L, Griffiths M, et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood. 2004;103:2410\u20136.","journal-title":"Blood"},{"key":"976_CR22","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood-2004-03-1040","volume":"104","author":"Y Miura","year":"2004","unstructured":"Miura Y, Thoburn CJ, Bright EC, Phelps ML, Shin T, Matsui EC, et al. Association of Foxp3 regulatory T cells gene expression with graft-versus-host disease. Blood. 2004;104:2187\u201393.","journal-title":"Blood"},{"key":"976_CR23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbmt.2004.04.002","volume":"10","author":"PJ Martin","year":"2004","unstructured":"Martin PJ, Pei J, Gooley T, Anasetti C, Appelbaum FR, Deeg J, et al. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. Biol Blood Marrow Transplant. 2004;10:552\u201360.","journal-title":"Biol Blood Marrow Transplant"},{"key":"976_CR24","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood-2003-06-2085","volume":"103","author":"M Stanzani","year":"2004","unstructured":"Stanzani M, Martins SL, Saliba RM, St John LS, Bryan S, Couriel D, et al. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. Blood. 2004;103:1140\u20136.","journal-title":"Blood"},{"key":"976_CR25","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","volume":"106","author":"E Zorn","year":"2005","unstructured":"Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, et al. Reduced frequency of FOXP3+CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood. 2005;106:2903\u201311.","journal-title":"Blood"},{"key":"976_CR26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.exphem.2005.05.001","volume":"33","author":"V Meignin","year":"2005","unstructured":"Meignin V, Peffault de Latour R, Zuber J, R\u00e9gnault A, Mounier N, Lema\u00eetre F, et al. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation. Exp Hematol. 2005;33:894\u2013900.","journal-title":"Exp Hematol"},{"key":"976_CR27","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"976_CR28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","volume":"97","author":"PA Rowlings","year":"1997","unstructured":"Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97:855\u201364.","journal-title":"Br J Haematol"},{"key":"976_CR29","first-page":"1750","volume":"28","author":"T Kurihara","year":"1996","unstructured":"Kurihara T, Hayashi J, Ito A, Asai T. CMV antigenemia assay using indirect ALP-immunostaining in bone marrow transplant recipients. Transplant Proc. 1996;28:1750\u20133.","journal-title":"Transplant Proc."},{"key":"976_CR30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbmt.2010.02.026","volume":"16","author":"JM Magenau","year":"2010","unstructured":"Magenau JM, Qin X, Tawara I, Rogers CE, Kitko C, Schlough M, et al. Frequency of CD4+CD25highFOXP3+ regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010;16:907\u201314.","journal-title":"Biol Blood Marrow Transplant"},{"key":"976_CR31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI41072","volume":"120","author":"K Matsuoka","year":"2010","unstructured":"Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J, et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest. 2010;120:1479\u201393.","journal-title":"J Clin Invest"},{"key":"976_CR32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2009-12-255810","volume":"116","author":"P Ratajczak","year":"2010","unstructured":"Ratajczak P, Janin A, Peffault de Latour R, Leboeuf C, Desveaux A, et al. Th17\/Treg ratio in human graft-versus-host disease. Blood. 2010;116:1165\u201371.","journal-title":"Blood"},{"key":"976_CR33","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2005-06-2529","volume":"107","author":"K Rieger","year":"2006","unstructured":"Rieger K, Loddenkemper C, Maul J, Fietz T, Wolff D, Terpe H, et al. Mucosal FOXP3+\u00a0regulatory T cells are numerically deficient in acute and chronic GvHD. Blood. 2006;107:1717\u201323.","journal-title":"Blood"},{"key":"976_CR34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbmt.2010.04.011","volume":"17","author":"D Pastore","year":"2011","unstructured":"Pastore D, Delia M, Mestice A, Perrone T, Carluccio P, Gaudio F, Giordano A, Rossi AR, Ricco A, Leo M, Liso V, Specchia G. Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:550\u20137.","journal-title":"Biol Blood Marrow Transplant."},{"key":"976_CR35","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2009.05.015","volume":"15","author":"K Le Blanc","year":"2009","unstructured":"Le Blanc K, Barrett AJ, Schaffer M, H\u00e4gglund H, Ljungman P, Ringd\u00e9n O, et al. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant. 2009;15:1108\u201315.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0976-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-011-0976-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0976-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T19:14:22Z","timestamp":1686510862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-011-0976-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s12185-011-0976-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}